Cargando…

Costs of medical care for mesothelioma

Malignant mesothelioma is a rare and devastating form of cancer with an increasing economic burden. We sought to describe the direct cost burden of mesothelioma to the US health system. A systematic literature review was performed to locate published estimates of the medical cost of mesothelioma. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borrelli, Eric, Babcock, Zachary, Kogut, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637828/ https://www.ncbi.nlm.nih.gov/pubmed/31360386 http://dx.doi.org/10.1177/2036361319863498

Ejemplares similares

Real-World Health Care Costs Based on Medication Adherence and Risk of Stroke and Bleeding in Patients Treated with Novel Anticoagulant Therapy
por: Deshpande, Chinmay G., et al.
Publicado: (2018)

PHARMACY DEDUCTIBLES CAN COMPLICATE THE RELATIONSHIP BETWEEN MEASURES OF PATIENT COST SHARING AND MEDICATION ADHERENCE
por: Kogut, Stephen J, et al.
Publicado: (2023)

Racial disparities in medication use: imperatives for managed care pharmacy
por: Kogut, Stephen J
Publicado: (2020)

Standards of care in mesothelioma treatment
por: Harden, Susan V., et al.
Publicado: (2020)

Application of a diazepam milligram equivalency algorithm to assess benzodiazepine dose intensity in Rhode Island in 2018
por: Borrelli, Eric P, et al.
Publicado: (2022)

Evaluation of a Program to Improve Diabetes Care Through Intensified Care Management Activities and Diabetes Medication Copayment Reduction
por: Kogut, Stephen J., et al.
Publicado: (2012)

Improving outcomes in malignant pleural mesothelioma in an integrated health care system
por: Ossowski, Stephanie, et al.
Publicado: (2022)

Investigational Approaches for Mesothelioma
por: Surmont, Veerle F., et al.
Publicado: (2011)

Mesothelioma
por: Rao, Nagarjun, et al.
Publicado: (2022)

Mesothelioma
por: Deraco, Marcello
Publicado: (2021)

Malignant mesothelioma: health care awareness and preparedness
por: Capitani, Eduardo Mello De, et al.
Publicado: (2022)

Update on Lung Cancer and Mesothelioma
por: Brown, Jerry S, et al.
Publicado: (1999)

Do Triptan Antimigraine Medications Interact with SSRI/SNRI Antidepressants? What Does Your Decision Support System Say?
por: Kogut, Stephen J.
Publicado: (2011)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Shipbuilding and mesothelioma in Monfalcone, Italy
por: Bianchi, Claudio, et al.
Publicado: (2012)

Extrathoracic Metastases in Pleural Mesothelioma
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

Malignant Peritoneal Mesothelioma Presenting as Mucinous Ascites
por: Field, Zachary, et al.
Publicado: (2018)

Peritoneal mesothelioma.
por: Kealey, W. D., et al.
Publicado: (1993)

Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001)

Peritoneal mesothelioma.
por: Churg, J
Publicado: (1974)

Malignant mesothelioma
por: Ahmed, Ishtiaq, et al.
Publicado: (2013)

Peritoneal mesothelioma
por: Greenbaum, Alissa, et al.
Publicado: (2020)

MicroRNA-31 Regulates Chemosensitivity in Malignant Pleural Mesothelioma
por: Moody, Hannah L., et al.
Publicado: (2017)

Mesothelioma Risk among Construction Workers According to Job Title: Data from the Italian Mesothelioma Register
por: Vimercati, Luigi, et al.
Publicado: (2023)

Malignant mesothelioma
por: Moore, Alastair J, et al.
Publicado: (2008)

Malignant Mesothelioma
por: Pouliquen, Daniel L., et al.
Publicado: (2021)

Global mesothelioma epidemic: Trend and features
por: Bianchi, Claudio, et al.
Publicado: (2014)

Targeting YAP in malignant pleural mesothelioma
por: Zhang, Wen‐Qian, et al.
Publicado: (2017)

Management of malignant pleural mesothelioma – part 3: Data from the Austrian Mesothelioma Interest Group (AMIG) database
por: Klikovits, Thomas, et al.
Publicado: (2016)

Cost-effectiveness analysis of nivolumab plus ipilimumab versus chemotherapy as the first-line treatment for unresectable malignant pleural mesothelioma
por: Yang, Liu, et al.
Publicado: (2022)

Medical Care Costs Associated With Progression of Diabetic Nephropathy
por: Nichols, Gregory A., et al.
Publicado: (2011)

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma
por: Hudson, Amanda L., et al.
Publicado: (2014)

High-cost users of medical care
por: Garfinkel, Steven A., et al.
Publicado: (1988)

Hypernephroma or Mesothelioma of the Kidney
por: Swain, James
Publicado: (1913)

Epidemiology and Etiology of Mesothelioma
por: Papiris, Spyros A., et al.
Publicado: (2006)

Development and Application of a Measurement Framework to Evaluate Safe, Effective and Efficient Medication Use Among Older Adults
por: Vyas, Ami, et al.
Publicado: (2019)

Well-Differentiated Papillary Mesothelioma of the Peritoneum Is Genetically Distinct from Malignant Mesothelioma
por: Shrestha, Raunak, et al.
Publicado: (2020)

Cost–Benefit Analysis of the COPE Program for Persons Living With Dementia: Toward a Payment Model
por: Pizzi, Laura T, et al.
Publicado: (2021)

The European mesothelioma epidemic
por: Peto, J, et al.
Publicado: (1999)

Improving medication management after a hospitalization with pharmacist home visits and electronic personal health records: an observational study
por: Kogut, Stephen Jon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k637miecpp2m8jofpavjgbv4oo